Tablet and formulation

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514781, 514960, A61K 3147, A61K 920

Patent

active

046394583

ABSTRACT:
A direct compression tablet formulation containing a non-hydrated quinoline carboxylic acid type antibacterial agent.

REFERENCES:
patent: Re29077 (1976-12-01), Geller
patent: 3873694 (1975-03-01), Kanig
patent: 4072535 (1978-02-01), Short et al.
patent: 4097606 (1978-06-01), Chavkin et al.
patent: 4293539 (1981-10-01), Ludwig et al.
patent: 4369172 (1983-01-01), Schor et al.
patent: 4370313 (1983-01-01), Davies
patent: 4440740 (1984-04-01), Fix et al.
patent: 4478822 (1984-10-01), Haslam et al.
patent: 4517179 (1985-05-01), Raghunathan
patent: 4522818 (1985-06-01), Raghunathan
patent: 4530928 (1985-07-01), Haslam et al.
patent: 4540602 (1985-09-01), Motoyama et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tablet and formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tablet and formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tablet and formulation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-858212

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.